{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:00:29Z","timestamp":1769162429522,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11096-017-0529-0","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T11:08:42Z","timestamp":1504609722000},"page":"1273-1281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants?"],"prefix":"10.1007","volume":"39","author":[{"given":"Nadya","family":"Hamedi","sequence":"first","affiliation":[]},{"given":"Filipa Alves","family":"da Costa","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Horne","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Levitan","sequence":"additional","affiliation":[]},{"given":"Amanda","family":"Begley","sequence":"additional","affiliation":[]},{"given":"Sotiris","family":"Antoniou","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"529_CR1","unstructured":"Public Health England. Atrial Fibrillation estimates in England: Application of recent population estimates of AF in Sweden. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/612288\/AtrialfibrillationprevalenceestimatesinEngland.pdf (2015). Accessed 22 June 2017."},{"key":"529_CR2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983\u20138.","journal-title":"Stroke"},{"key":"529_CR3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","volume":"36","author":"C Marini","year":"2005","unstructured":"Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A. Contribution of atrial fibrillation to incidence and outcomes of ischaemic stroke: results from a population-based study. Stroke. 2005;36:1115\u20139.","journal-title":"Stroke"},{"key":"529_CR4","unstructured":"Royal College of Physicians Sentinel Stroke National Audit Programme (SSNAP). Clinical audit April\u2013June 2014 report prepared by Royal College of Physicians, Clinical Effectiveness and Evaluation Unit on behalf of the Intercollegiate Stroke Working Party."},{"key":"529_CR5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archinte.1997.00440320143013","volume":"157","author":"Atrial fibrillation investigators","year":"1997","unstructured":"Atrial fibrillation investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials. Arch Intern Med. 1997;157:1237\u201340.","journal-title":"Arch Intern Med"},{"key":"529_CR6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367.","journal-title":"Ann Intern Med"},{"issue":"16","key":"529_CR7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/heartjnl-2012-303472","volume":"99","author":"C Cowan","year":"2013","unstructured":"Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M, et al. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart. 2013;99(16):1166\u201372.","journal-title":"Heart"},{"key":"529_CR8","unstructured":"National Institute for Health and Care Excellence. Atrial fibrillation: management of atrial fibrillation. http:\/\/www.nice.org.uk\/guidance\/cg180 (2014). Accessed 14 Jan 2015."},{"issue":"10","key":"529_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Barry M. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361\u20137. doi: 10.1007\/s11606-012-2077-6 .","journal-title":"J Gen Intern Med"},{"key":"529_CR10","unstructured":"National Patient Safety Agency. Action that can make anticoagulant therapy safer: Alert & information. http:\/\/www.nrls.npsa.nhs.uk\/resources\/?entryid45=59814 (2007). Accessed 14 Jan 2015."},{"issue":"9508","key":"529_CR11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","volume":"367","author":"C Heneghan","year":"2006","unstructured":"Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367(9508):404\u201311.","journal-title":"Lancet"},{"key":"529_CR12","unstructured":"Anticoagulation Self-monitoring Alliance. Anticoagulation services and patient access to INR self-monitoring in the NHS in England. http:\/\/www.anticoagulationeurope.org\/files\/files\/ACSMA%20Anticoagulation%20Services%20in%20England%20Report%20.pdf (2014). Accessed 24 June 2017."},{"key":"529_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/europace\/eut083","volume":"15","author":"H Heidbuchel","year":"2013","unstructured":"Heidbuchel H, Verhamme P, Aligns M, Antz M, Hacke W, Oldgren J, et al. European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013;15:625\u201351.","journal-title":"Europace"},{"key":"529_CR14","doi-asserted-by":"crossref","DOI":"10.7249\/RR1053","volume-title":"The future of anticoagulation management in atrial fibrillation in Europe. An assessment of today\u2019s challenges with recommendation for the future","author":"C Lichten","year":"2015","unstructured":"Lichten C, Castle-Clarke S, Manville C, Horvath V, Robin E, Krapels J, et al. The future of anticoagulation management in atrial fibrillation in Europe. An assessment of today\u2019s challenges with recommendation for the future. Cambridge: RAND Europe; 2015."},{"key":"529_CR15","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1096242","author":"C McHorney","year":"2015","unstructured":"McHorney C, Crivera C, Lalibert\u00e9 F, Nelson WW, Germain G, Bookhart B, et al. Adherence to non-VKA oral anticoagulant medications based on the pharmacy quality alliance measure. Curr Med Res Opin. 2015;. doi: 10.1185\/03007995.2015.1096242 .","journal-title":"Curr Med Res Opin"},{"key":"529_CR16","unstructured":"National Institute for Health and Care Excellence. Medicine Optimisation: the safe and effective use of medicines to enable the best possible outcome (NG5). March 2015. https:\/\/www.nice.org.uk\/guidance\/ng5\/resources\/medicines-optimisation-the-safe-and-effective-use-of-medicines-to-enable-the-best-possible-outcomes-51041805253 (2015). Accessed 15 January 2015."},{"key":"529_CR17","volume-title":"Adherence to long term therapies. Evidence for action","author":"World Health Organisation","year":"2003","unstructured":"World Health Organisation. Adherence to long term therapies. Evidence for action. Geneva: WHO; 2003."},{"issue":"2","key":"529_CR18","first-page":"CD000011","volume":"2","author":"RB Haynes","year":"2008","unstructured":"Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence (Review). Cochrane Database Syst Rev. 2008;2(2):CD000011.","journal-title":"Cochrane Database Syst Rev"},{"key":"529_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/qshc.2003.005926","volume":"13","author":"N Barber","year":"2004","unstructured":"Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients problems with new medication for chronic conditions. Qual Saf Health care. 2004;13:172\u20135.","journal-title":"Qual Saf Health care"},{"key":"529_CR20","first-page":"165","volume-title":"Pharm Pract","author":"R Horne","year":"2001","unstructured":"Horne R. Compliance, adherence and concordance. In: Taylor K, Harding G, editors. Pharm Pract. London: Taylor and Francis; 2001. p. 165\u201384."},{"key":"529_CR21","first-page":"40","volume-title":"Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities","author":"RR Horne","year":"2005","unstructured":"Horne RR, Weinman J, Barber N, Elliot R, Morgan M, Cribb A, Kellar I. Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities. London: NCCSDO; 2005. p. 40\u20136."},{"issue":"3","key":"529_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11096-006-9026-6","volume":"28","author":"S Clifford","year":"2006","unstructured":"Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006;28(3):165\u201370.","journal-title":"Pharm World Sci"},{"key":"529_CR23","unstructured":"Pharmaceutical Service Negotiating Committee. New Medicine Service [Internet]. http:\/\/psnc.org.uk\/services-commissioning\/advanced-services\/nms\/ (2011). Accessed 14 Jan 2015."},{"key":"529_CR24","volume-title":"A randomised controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicines Service in community pharmacies in England","author":"R Elliott","year":"2014","unstructured":"Elliott R, Boyd M, Waring J, Barber N, Mehta R, Chuter A, Avery A, Understanding appraising the new medicines service in the NHS in England. A randomised controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicines Service in community pharmacies in England. Nottingham: The School of Pharmacy University of Nottingham; 2014."},{"key":"529_CR25","unstructured":"Centre for Pharmacy Postgraduate Education. Learning programmes and assessments. https:\/\/www.cppe.ac.uk\/programmes\/l\/nms-e-01 (2015). Accessed 14 Jan 2015."},{"key":"529_CR26","unstructured":"Health Education England. The community pharmacy workforce in London 2015: Executive summary."},{"issue":"10","key":"529_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5688\/ajpe7710209","volume":"77","author":"CJ Boyle","year":"2013","unstructured":"Boyle CJ, Robinson ET. Leadership is not a soft skill. Am J Pharm Educ. 2013;77(10):209.","journal-title":"Am J Pharm Educ"},{"key":"529_CR28","unstructured":"Health & Social Care Information Centre. General Pharmaceutical Services. England 2004\u201305 to 2013\u201314. November 2014. http:\/\/www.hscic.gov.uk\/catalogue\/PUB15933\/gen-pharm-eng-201314-Report.pdf (2014). Accessed 14 Jan 2015."},{"key":"529_CR29","unstructured":"National Health Service. The NHS constitution. The NHS belongs to us all. https:\/\/www.gov.uk\/government\/publications\/the-nhs-constitution-for-england (2013). Assessed 24 June 2017."},{"key":"529_CR30","unstructured":"Anticoagulation forum. http:\/\/www.acforum.org (2015). Accessed 14 Jan 2015."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-017-0529-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0529-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0529-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T04:23:45Z","timestamp":1570076625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-017-0529-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1007\/s11096-017-0529-0","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]}}}